Technical Analysis for GNMK - GenMark Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 6.01 1.01% 0.06
GNMK closed up 1.01 percent on Friday, September 13, 2019, on 37 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical GNMK trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
20 DMA Resistance Bearish 1.01%
20 DMA Resistance Bearish -1.80%
Lower Bollinger Band Walk Weakness 3.26%
Lower Bollinger Band Touch Weakness 3.26%
New Downtrend Bearish 2.21%
Lower Bollinger Band Touch Weakness 2.21%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Spinning Top Other 0.00%

Older signals for GNMK ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GenMark Diagnostics, Inc., a molecular diagnostics company, engages in the development, manufacturing, marketing, sale, and support of instruments and molecular tests based on its proprietary eSensor detection technology in the United States. The company's products include XT-8 system, an automated molecular diagnostic system that enables reference laboratories and hospitals to perform molecular diagnostic tests. It also offers 8 diagnostic tests for use with its XT-8 system that includes Cystic Fibrosis Genotyping Test, which detects a panel of mutations associated with cystic fibrosis; Warfarin Sensitivity test that determines an individual's ability to metabolize the oral anticoagulant warfarin; Thrombophilia Risk Test, which detects an individual's increased risk of blood clots; and Respiratory Viral Panel test that simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illnesses. The company's diagnostic tests also include Hepatitis C Virus Genotyping test for the detection and typing/subtyping of HCV; 3A4/3A5 Genotyping test designed for the detection and genotyping of the alleles of the CYP450 3A4 gene locus and CYP450 3A5 gene locus; and 2C19 Genotyping test for the detection and genotyping alleles of the cytochrome P450 (CYP450) 2C19 gene locus. In addition, the company engages in developing a NexGen system to integrate automated nucleic acid extraction and amplification with its eSensor detection technology to enable technicians to place a patient sample into test cartridge and obtain results without any additional steps. Genmark Diagnostics, Inc. is headquartered in Carlsbad, California.
Biotechnology Manufacturing Biology Genetics Medical Genetics Medical Tests Diagnostic Tests Cystic Fibrosis Molecular Diagnostics Genotyping HCV Blood Clots Innogenetics
Is GNMK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.37
52 Week Low 3.58
Average Volume 337,160
200-Day Moving Average 6.4277
50-Day Moving Average 6.261
20-Day Moving Average 6.088
10-Day Moving Average 5.955
Average True Range 0.2751
ADX 25.17
+DI 13.4989
-DI 20.9966
Chandelier Exit (Long, 3 ATRs ) 5.7847
Chandelier Exit (Short, 3 ATRs ) 6.4453
Upper Bollinger Band 6.4582
Lower Bollinger Band 5.7178
Percent B (%b) 0.39
BandWidth 12.161629
MACD Line -0.1071
MACD Signal Line -0.1117
MACD Histogram 0.0046
Fundamentals Value
Market Cap 328.55 Million
Num Shares 54.7 Million
EPS -1.22
Price-to-Earnings (P/E) Ratio -4.93
Price-to-Sales 8.35
Price-to-Book 4.53
PEG Ratio 0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.52
Resistance 3 (R3) 6.50 6.32 6.44
Resistance 2 (R2) 6.32 6.19 6.33 6.41
Resistance 1 (R1) 6.16 6.11 6.24 6.18 6.38
Pivot Point 5.98 5.98 6.02 5.99 5.98
Support 1 (S1) 5.82 5.85 5.90 5.84 5.64
Support 2 (S2) 5.64 5.77 5.65 5.61
Support 3 (S3) 5.48 5.64 5.59
Support 4 (S4) 5.50